Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313197654> ?p ?o ?g. }
- W4313197654 endingPage "468" @default.
- W4313197654 startingPage "458" @default.
- W4313197654 abstract "As a complication of Type II Diabetes Mellitus (T2DM), the etiology, pathogenesis, and treatment of cognitive dysfunction are still undefined. Recent studies demonstrated that Ginsenoside Rg1 (Rg1) has promising neuroprotective properties, but the effect and mechanism in diabetes-associated cognitive dysfunction (DACD) deserve further investigation. After establishing the T2DM model with a high-fat diet and STZ intraperitoneal injection, Rg1 was given for 8 weeks. The behavior alterations and neuronal lesions were judged using the open field test (OFT) and Morris water maze (MWM), as well as HE and Nissl staining. The protein or mRNA changes of NOX2, p-PLC, TRPC6, CN, NFAT1, APP, BACE1, NCSTN, and Aβ1-42 were investigated by immunoblot, immunofluorescence or qPCR. Commercial kits were used to evaluate the levels of IP3, DAG, and calcium ion (Ca2+) in brain tissues. Rg1 therapy improved memory impairment and neuronal injury, decreased ROS, IP3, and DAG levels to revert Ca2+ overload, downregulated the expressions of p-PLC, TRPC6, CN, and NFAT1 nuclear translocation, and alleviated Aβ deposition in T2DM mice. In addition, Rg1 therapy elevated the expression of PSD95 and SYN in T2DM mice, which in turn improved synaptic dysfunction. Rg1 therapy may improve neuronal injury and DACD via mediating PLC–CN–NFAT1 signal pathway to reduce Aβ generation in T2DM mice." @default.
- W4313197654 created "2023-01-06" @default.
- W4313197654 creator A5012429119 @default.
- W4313197654 creator A5013861588 @default.
- W4313197654 creator A5039637336 @default.
- W4313197654 creator A5054199213 @default.
- W4313197654 creator A5063333118 @default.
- W4313197654 creator A5065051137 @default.
- W4313197654 creator A5077084630 @default.
- W4313197654 date "2023-05-01" @default.
- W4313197654 modified "2023-10-18" @default.
- W4313197654 title "Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice" @default.
- W4313197654 cites W1481122508 @default.
- W4313197654 cites W1936450020 @default.
- W4313197654 cites W1966855400 @default.
- W4313197654 cites W1967516419 @default.
- W4313197654 cites W1974888639 @default.
- W4313197654 cites W1988278010 @default.
- W4313197654 cites W1995650022 @default.
- W4313197654 cites W1999688892 @default.
- W4313197654 cites W2002521377 @default.
- W4313197654 cites W2008958059 @default.
- W4313197654 cites W2009611544 @default.
- W4313197654 cites W2013343090 @default.
- W4313197654 cites W2016049951 @default.
- W4313197654 cites W2035763500 @default.
- W4313197654 cites W2036145275 @default.
- W4313197654 cites W2036179978 @default.
- W4313197654 cites W2037894403 @default.
- W4313197654 cites W2039534328 @default.
- W4313197654 cites W2043108620 @default.
- W4313197654 cites W2065014879 @default.
- W4313197654 cites W2073275629 @default.
- W4313197654 cites W2078437085 @default.
- W4313197654 cites W2089189236 @default.
- W4313197654 cites W2092902171 @default.
- W4313197654 cites W2119171474 @default.
- W4313197654 cites W2153444597 @default.
- W4313197654 cites W2325596649 @default.
- W4313197654 cites W2512955684 @default.
- W4313197654 cites W2608729270 @default.
- W4313197654 cites W2755558750 @default.
- W4313197654 cites W2765466703 @default.
- W4313197654 cites W2786817927 @default.
- W4313197654 cites W2789371571 @default.
- W4313197654 cites W2884234047 @default.
- W4313197654 cites W2888239039 @default.
- W4313197654 cites W2888731399 @default.
- W4313197654 cites W2906474750 @default.
- W4313197654 cites W2931408287 @default.
- W4313197654 cites W2932523985 @default.
- W4313197654 cites W2953967368 @default.
- W4313197654 cites W2963234188 @default.
- W4313197654 cites W2979352150 @default.
- W4313197654 cites W2990137262 @default.
- W4313197654 cites W2994500484 @default.
- W4313197654 cites W3006858961 @default.
- W4313197654 cites W3008031857 @default.
- W4313197654 cites W3045775068 @default.
- W4313197654 cites W3048816011 @default.
- W4313197654 cites W3082887694 @default.
- W4313197654 cites W3118912716 @default.
- W4313197654 cites W3138848822 @default.
- W4313197654 cites W3151625953 @default.
- W4313197654 cites W3166024029 @default.
- W4313197654 cites W3195925410 @default.
- W4313197654 cites W3196563535 @default.
- W4313197654 cites W3208984739 @default.
- W4313197654 cites W4200026682 @default.
- W4313197654 cites W4205557970 @default.
- W4313197654 cites W4205828268 @default.
- W4313197654 cites W4220797459 @default.
- W4313197654 cites W4233547545 @default.
- W4313197654 doi "https://doi.org/10.1016/j.jgr.2022.12.006" @default.
- W4313197654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37252275" @default.
- W4313197654 hasPublicationYear "2023" @default.
- W4313197654 type Work @default.
- W4313197654 citedByCount "1" @default.
- W4313197654 countsByYear W43131976542023 @default.
- W4313197654 crossrefType "journal-article" @default.
- W4313197654 hasAuthorship W4313197654A5012429119 @default.
- W4313197654 hasAuthorship W4313197654A5013861588 @default.
- W4313197654 hasAuthorship W4313197654A5039637336 @default.
- W4313197654 hasAuthorship W4313197654A5054199213 @default.
- W4313197654 hasAuthorship W4313197654A5063333118 @default.
- W4313197654 hasAuthorship W4313197654A5065051137 @default.
- W4313197654 hasAuthorship W4313197654A5077084630 @default.
- W4313197654 hasBestOaLocation W43131976541 @default.
- W4313197654 hasConcept C126322002 @default.
- W4313197654 hasConcept C134018914 @default.
- W4313197654 hasConcept C25498285 @default.
- W4313197654 hasConcept C2779280383 @default.
- W4313197654 hasConcept C2780159080 @default.
- W4313197654 hasConcept C2781161787 @default.
- W4313197654 hasConcept C44752575 @default.
- W4313197654 hasConcept C555293320 @default.
- W4313197654 hasConcept C71924100 @default.
- W4313197654 hasConcept C98274493 @default.